In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Royalty Pharma

www.royaltypharma.com

Latest From Royalty Pharma

Finance Watch: As US IPO Market Gets More Challenging, Two Companies Opt Out

Public Company Edition: Five biopharma firms went public in the US in recent weeks, but Inhibrx withdrew its IPO and Monopar postponed its offering. Also, Tot Biopharm launched an IPO in Hong Kong, while Epizyme sold royalties and issued debt to raise up to $270m.

Financing Business Strategies

Another Change At Perrigo Helm As Results Remain Turbulent

Incoming CEO Murray Kessler is a seasoned veteran of regulated consumer markets – but not health care. Will his combination of experience and fresh perspective help enable the OTC private label market leader to reverse share declines?

Appointments Prescription To Otc Switch

Another Change At Perrigo Helm As Results Remain Turbulent

Incoming CEO Murray Kessler is a seasoned veteran of regulated consumer markets – but not health care. Will his combination of experience and fresh perspective help enable the OTC private label market leader to reverse share declines?

Appointments Prescription To Otc Switch

Another Change At Perrigo Helm As Results Remain Turbulent

Incoming CEO Murray Kessler is a seasoned veteran of regulated consumer markets – but not health care. Will his combination of experience and fresh perspective help enable the OTC private label market leader to reverse share declines?

Appointments Prescription To Otc Switch
See All

Company Information

  • Industry
  • Miscellaneous
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Royalty Pharma AG
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Royalty Pharma
  • Senior Management
  • Pablo Legorreta, CEO
    Susannah Gray, EVP, CFO
  • Contact Info
  • Royalty Pharma
    Phone: (41)(212) 883-0200
    110 East 59th St.
    33rd Fl.
    New York, NY 10022
    USA
UsernamePublicRestriction

Register